VIM and Parkinson disease: Considering the emerging evidence in regard to the neuroprotective effects of withaferin A in PD-related cell and animal models (71, 72), our findings highlight the intervention potential of targeting the vimentin pathway to protect against aSyn-mediated neurite degeneration, a very early cellular event in neurodegeneration.